122 related articles for article (PubMed ID: 37084480)
1. Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver disease.
Bjune MS; Lawrence-Archer L; Laupsa-Borge J; Sommersten CH; McCann A; Glastad RC; Johnston IG; Kern M; Blüher M; Mellgren G; Dankel SN
EBioMedicine; 2023 May; 91():104569. PubMed ID: 37084480
[TBL] [Abstract][Full Text] [Related]
2. Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats.
Bjune MS; Lindquist C; Hallvardsdotter Stafsnes M; Bjørndal B; Bruheim P; Aloysius TA; Nygård O; Skorve J; Madsen L; Dankel SN; Berge RK
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Apr; 1866(4):158887. PubMed ID: 33454435
[TBL] [Abstract][Full Text] [Related]
3. Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism.
Jersin RÅ; Sri Priyanka Tallapragada D; Skartveit L; Bjune MS; Muniandy M; Lee-Ødegård S; Heinonen S; Alvarez M; Birkeland KI; André Drevon C; Pajukanta P; McCann A; Pietiläinen KH; Claussnitzer M; Mellgren G; Dankel SN
J Clin Endocrinol Metab; 2023 Aug; 108(9):2217-2229. PubMed ID: 36916878
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxyisobutyrate, A Strong Marker of Insulin Resistance in Type 2 Diabetes and Obesity That Modulates White and Brown Adipocyte Metabolism.
Nilsen MS; Jersin RÅ; Ulvik A; Madsen A; McCann A; Svensson PA; Svensson MK; Nedrebø BG; Gudbrandsen OA; Tell GS; Kahn CR; Ueland PM; Mellgren G; Dankel SN
Diabetes; 2020 Sep; 69(9):1903-1916. PubMed ID: 32586980
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of valine and its metabolite in improving triglyceride synthesis of porcine intestinal epithelial cells.
Xu M; Che L; Niu L; Wang L; Li M; Jiang D; Deng H; Chen W; Jiang Z
Sci Rep; 2023 Feb; 13(1):2933. PubMed ID: 36806358
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
[TBL] [Abstract][Full Text] [Related]
7. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
9. Targeting HIBCH to reprogram valine metabolism for the treatment of colorectal cancer.
Shan Y; Gao Y; Jin W; Fan M; Wang Y; Gu Y; Shan C; Sun L; Li X; Yu B; Luo Q; Xu Q
Cell Death Dis; 2019 Aug; 10(8):618. PubMed ID: 31409769
[TBL] [Abstract][Full Text] [Related]
10. The branched-chain amino acids valine and leucine have differential effects on hepatic lipid metabolism.
Bishop CA; Schulze MB; Klaus S; Weitkunat K
FASEB J; 2020 Jul; 34(7):9727-9739. PubMed ID: 32506644
[TBL] [Abstract][Full Text] [Related]
11. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.
Jang C; Oh SF; Wada S; Rowe GC; Liu L; Chan MC; Rhee J; Hoshino A; Kim B; Ibrahim A; Baca LG; Kim E; Ghosh CC; Parikh SM; Jiang A; Chu Q; Forman DE; Lecker SH; Krishnaiah S; Rabinowitz JD; Weljie AM; Baur JA; Kasper DL; Arany Z
Nat Med; 2016 Apr; 22(4):421-6. PubMed ID: 26950361
[TBL] [Abstract][Full Text] [Related]
12. ECHS1 mutations in Leigh disease: a new inborn error of metabolism affecting valine metabolism.
Peters H; Buck N; Wanders R; Ruiter J; Waterham H; Koster J; Yaplito-Lee J; Ferdinandusse S; Pitt J
Brain; 2014 Nov; 137(Pt 11):2903-8. PubMed ID: 25125611
[TBL] [Abstract][Full Text] [Related]
13. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Zhao Y; Li Z; Wang C
Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
[TBL] [Abstract][Full Text] [Related]
15. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
16. Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr-/-.Leiden mice with manifest obesity-associated NASH.
Gart E; van Duyvenvoorde W; Caspers MPM; van Trigt N; Snabel J; Menke A; Keijer J; Salic K; Morrison MC; Kleemann R
FASEB J; 2022 Aug; 36(8):e22435. PubMed ID: 35830259
[TBL] [Abstract][Full Text] [Related]
17. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
Ganji SH; Kashyap ML; Kamanna VS
Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
[TBL] [Abstract][Full Text] [Related]
18. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
19. AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease.
Nikolaou N; Gathercole LL; Marchand L; Althari S; Dempster NJ; Green CJ; van de Bunt M; McNeil C; Arvaniti A; Hughes BA; Sgromo B; Gillies RS; Marschall HU; Penning TM; Ryan J; Arlt W; Hodson L; Tomlinson JW
Metabolism; 2019 Oct; 99():67-80. PubMed ID: 31330134
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
Sun N; Shen C; Zhang L; Wu X; Yu Y; Yang X; Yang C; Zhong C; Gao Z; Miao W; Yang Z; Gao W; Hu L; Williams K; Liu C; Chang Y; Gao Y
Gut; 2021 Nov; 70(11):2183-2195. PubMed ID: 33257471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
